Jorge Rubio‐Gracia

ORCID: 0000-0002-4769-7154
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Ultrasound in Clinical Applications
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular Function and Risk Factors
  • Cardiac, Anesthesia and Surgical Outcomes
  • Acute Kidney Injury Research
  • Abdominal Surgery and Complications
  • Respiratory Support and Mechanisms
  • Sepsis Diagnosis and Treatment
  • Potassium and Related Disorders
  • Nutrition and Health in Aging
  • IL-33, ST2, and ILC Pathways
  • Cardiac pacing and defibrillation studies
  • Immune Cell Function and Interaction
  • Phonocardiography and Auscultation Techniques
  • COVID-19 Clinical Research Studies
  • Cardiac Arrest and Resuscitation
  • Cardiac Structural Anomalies and Repair
  • Acute Myocardial Infarction Research
  • Muscle and Compartmental Disorders
  • Aging, Health, and Disability
  • Galectins and Cancer Biology
  • Healthcare Systems and Technology
  • Dialysis and Renal Disease Management
  • Cancer Diagnosis and Treatment

Hospital Clínico Universitario Lozano Blesa
2016-2025

Instituto de Investigación Sanitaria Aragón
2016-2025

Universidad de Zaragoza
2018-2025

University Medical Center Groningen
2018

University of Groningen
2018

Background Lung ultrasound is feasible for assessing lung injury caused by coronavirus disease 2019 (COVID-19). However, the prognostic meaning and time-line changes of assessed in COVID-19 hospitalised patients are unknown. Methods Prospective cohort study designed to analyse value using a quantitative scale (lung Zaragoza (LUZ)-score) during first 72 h after admission. The primary end-point was in-hospital death and/or admission intensive care unit. Total length hospital stay, increase...

10.1183/13993003.04283-2020 article EN cc-by-nc European Respiratory Journal 2021-02-11

As part of the “2nd Training Conference on Heart Failure and Atrial Fibrillation for Residents”, held in Madrid November 2024, a collaborative initiative was launched to address most common practical challenges management heart failure (HF) daily practice. This document is result joint efforts residents from various hospitals nationwide, collaboration with senior physicians extensive HF expertise members Working Group Spanish Society Internal Medicine. Our aim provide useful tool that...

10.20944/preprints202504.2128.v1 preprint EN 2025-04-25

Although several biomarkers have shown correlation to prognosis in COVID-19 patients, their clinical value is limited because of lack specificity, suboptimal sensibility or poor dynamic behavior. We hypothesized that circulating soluble ST2 (sST2) could be associated a worse outcome COVID-19. In total, 152 patients admitted for confirmed were included prospective non-interventional, observational study. Blood samples drawn at admission, 48-72 h later and discharge. sST2 concentrations...

10.3390/jcm10163534 article EN Journal of Clinical Medicine 2021-08-11

Background: Risk stratification of COVID-19 patients is fundamental to improving prognosis and selecting the right treatment. We hypothesized that a combination lung ultrasound (LUZ-score), biomarkers (sST2), clinical models (PANDEMYC score) could be useful improve risk stratification. Methods: This was prospective cohort study designed analyze prognostic value ultrasound, sST2, PANDEMYC score in patients. The primary endpoint in-hospital death and/or admission intensive care unit. total...

10.3390/jcm10235478 article EN Journal of Clinical Medicine 2021-11-23

Increased intra-abdominal pressure (IAP) is now considered a potential contributor to organ damage and disease progression in acute heart failure (AHF). In this work, we aimed determine if antigen carbohydrate 125 (CA125) associated with IAP identify cutpoint of CA125 useful for ruling out hypertension (defined as ≥ 12 mmHg). We prospectively evaluated cohort 53 patients admitted AHF which was measured within the first 24-h admission. The mean age 80 ± 8 years, 31 (58.5%) were female, had...

10.1093/ehjacc/zuac046 article EN European Heart Journal Acute Cardiovascular Care 2022-04-14

The coexistence of heart and kidney diseases, also called cardiorenal syndrome, is increasingly common, leads to a significant impact on morbidity mortality, poses diagnostic therapeutic difficulties. There risk-treatment paradox, such that patients with the highest risk are treated lesser disease-modifying medical therapies. In this document, different scientific societies propose practical approach systematically address optimize therapies related comorbidities in chronic disease beyond...

10.1159/000538125 article EN cc-by-nc Cardiorenal Medicine 2024-03-02

Background: Heart failure (HF) is a major and growing public health problem worldwide. Across the world, heart associated with high mortality, hospitalization rates, poor quality of life. Self-care defined as naturalistic decision-making process involving choice behaviors that maintain physiologic stability, response to symptoms when they occur, ability follow treatment regimen control symptoms. One instrument used measure self-care Self Care Failure Index. Aim: The purpose this study was...

10.3390/ijerph18020569 article EN International Journal of Environmental Research and Public Health 2021-01-12

Abstract Importance Although several biomarkers have shown correlation to prognosis in COVID-19 patients, their clinical value is limited because of lack specificity, suboptimal sensibility, or poor dynamic behavior. Objective In search better prognostic markers COVID-19, we hypothesized that circulating soluble ST2 (sST2) could be associated a worse outcome, prompted by our previous knowledge sST2 involvement heart failure-associated lung deterioration, and mounting evidence favoring role...

10.1101/2020.12.29.20248989 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-01-04

Hospitalization for acute decompensation of heart failure (ADHF) is a frequent event associated with long‑term adverse effects. Prognosis even worse if kidney injury (AKI) occurs during hospitalization.The study aimed to determine whether damage biomarkers neutrophil gelatinase‑associatedlipocalin (NGAL), molecule 1 (KIM‑1), and interleukin18 (IL‑18) might predict AKI have prognostic value in ADHF.Serum NGAL on admission urine NGAL, KIM‑1, IL‑18 discharge were determined 187 ADHF patients...

10.20452/pamw.16284 article EN Polskie Archiwum Medycyny Wewnętrznej 2022-07-01

Background: Congestion is an essential issue in patients with heart failure (HF). Standard treatments do not usually achieve decongestion, and various strategies have been proposed to guide treatment, such as determination of natriuresis. After starting treatment loop diuretics, we postulate that initial natriuresis might help titration, improve prognosis. Methods: It was a prospective observational study. Patients admitted the diagnosis HF decompensation were eligible. An assessment...

10.3390/jcm13041053 article EN Journal of Clinical Medicine 2024-02-12

Introduction and Objectives: A comprehensive assessment of congestion, including circulating biomarkers, is recommended in patients with acute heart failure. The biomarkers natriuretic peptides (NPs) carbohydrate antigen-125 (CA125) could be useful for congestion ambulatory chronic failure (CHF), but there only limited information about their applicability this context. Therefore, study aimed to examine the association plasma CA125 NP levels clinical ultrasound parameters CHF. Methods: This...

10.1159/000541324 article EN cc-by-nc Cardiorenal Medicine 2024-09-05
Coming Soon ...